FDA Expands Tzield to Children Age 1+ to Delay Type 1 Diabetes
Sanofi's disease-modifying therapy can now be used in children as young as 1 year old, opening a new window to delay type 1 diabetes progression in the youngest patients.
Sana Biotechnology and Mayo Clinic Team Up for Potential Type 1 Diabetes Cure
The two have partnered to develop SC451, an investigational cell therapy aiming to restore the body’s ability to regulate glucose and eliminate the need for both insulin and immunosuppressive therapy.
Blue Circle Gives Free Support to Adults with Type 1 Diabetes - How it Works
Nw operating in 20 states and Washington, D.C., Blue Circle Health is expanding free, comprehensive support for adults living with type 1 diabetes across the country.
CamDiab Unveils Fully Closed-Loop Feature on CamAPS FX
The new Liberty feature allows people with type 1 diabetes to temporarily stop counting carbs or deliver boluses while CamAPS FX automatically manages glucose levels.
Essential On-the-Go Diabetes Supplies: Coolers, Travel Bags & More
Here's a list of our go-to accessories from coolers, cases, and patches, to snacks that help keep your diabetes management on track no matter where you go.
An Islet Cell Transplant Without Immunosuppression Shows Promise - We Spoke with Patient #1
Encapsulated neonatal pig islet cells, implanted without immunosuppression in the OPF-310 trial, cut a type 1 diabetes patient’s insulin needs in half at six months, with further maturation expected.
Afrezza Launches Trial to Bring Inhaled Insulin to Children With Type 1 Diabetes
MannKind’s INHALE‐1ST trial is testing an inhaled insulin, as a needle‐free option for children with type 1 diabetes with an expected FDA decision by May 29, 2026.
twiist Pump Review - Here's What I Think After 2 Months Using it
I used the twiist insulin pump for over 2 months and break down how it works day to day, iPhone and app watch control, settings and alerts and my glucose control results.
As more insulin pumps move to pharmacy benefits, switching systems is easier than ever—but it’s also exposing serious gaps in safety, training, and support.
How Secure Is Your Insulin Pump? A Cybersecurity Expert Explains
A cybersecurity expert explains the precautions behind insulin pumps, CGMs, and why managing diabetes in secure government facilities requires a different level of protection.
We unpack how major companies are reimagining insulin delivery through tubeless designs, smarter algorithms, and the path to a fully automated insulin system.
We Spoke with Breakthrough T1D’s CEO About its Mission to Cure Type 1 Diabetes
We interviewed the CEO of Breakthrough T1D about how the organization reshaped diabetes tech over the years, and its latest endeavors aimed at speeding cell therapy research to cure type 1 diabetes.
Novo Nordisk Shuts Down Cell Therapy Unit—What the Community Is Saying
The move to end research into a potential type 1 diabetes cure has left many people with diabetes frustrated, reflective, and still holding on to hope.
FDA Moves Forward With Review Of Inhaled Insulin For Children
The FDA has accepted MannKind’s application to expand the use of its inhaled insulin, Afrezza, to children, marking a key step toward potential pediatric approval.
